22.01.2015 Views

Annual Activities Report 2011 - INCT-Inofar - UFRJ

Annual Activities Report 2011 - INCT-Inofar - UFRJ

Annual Activities Report 2011 - INCT-Inofar - UFRJ

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Annual</strong> <strong>Report</strong> <strong>2011</strong> | <strong>INCT</strong>-INOFAR<br />

Highlights<br />

highly comparable to that of the positive control Temik. Moreover, in anthelmintic assays against the<br />

gastrointestinal parasitic nematode Nippostrongylus brasiliensis (L4), some of the compounds, such as<br />

(6-chloropyrazin-2-yl)sulfanyl ethanol (32, EC 50<br />

= 33 nM), presented activities that were considerably<br />

stronger than that of the positive control albendazole (EC 50<br />

= 340 nM).<br />

In the light of the positive results obtained in the anthelmintic evaluations, the acute oral toxicity of<br />

the representative compound diethyl 2,2’-[(3-nitropyridine-2,6-diyl) bissulfanediyl] diacetate (7) was<br />

determined in rats, and the drug was shown to be non-toxic at a dose of 2000 mg/kg. These results, allied<br />

with the relatively simple structures of the active compounds and their facile synthesis, highlight their<br />

potential use as anthelmintic or nematicidic agents.<br />

Scheme (1). Synthesis of compounds 7 - 33. Reagents and conditions: a) ethyl-2-mercaptoacetate,<br />

NaH, anhydrous THF, N 2<br />

atmosphere, room temperature or ice bath, depending on the reaction, for 5<br />

min to 12 h, depending on the starting material; b) NaOH, EtOH/H 2<br />

O (2:1), room temperature for<br />

1 h; c) alcohol (MeOH, n-PrOH or n-BuOH), H 2<br />

SO 4<br />

, reflux for 12 h; d) LiAlH 4<br />

, anhydrous THF, N 2<br />

atmosphere, ice bath for 12 h; e) Feo, NH 4<br />

Cl, EtOH/H 2<br />

O (2:1), reflux for 90 min.<br />

Table 1. In vitro AChE inhibitory, nematostatic and anthelmintic activities of the most active compounds.<br />

Compound<br />

AChE inhibition (LOD, M. Incognita N. brasiliensis death<br />

nmol)<br />

immobilization (%) (EC 50<br />

, nM)<br />

7 8.6 12 56.0<br />

10 - 19 34.0<br />

11 13.0 98 -<br />

17 - - 230.0<br />

18 - - -<br />

21 - - 60.0<br />

26 12.0 - 69.0<br />

32 130.0 - 33.0<br />

a<br />

physostigmine | b Temik | c albendazole<br />

55<br />

Patent<br />

LC Dias, AS Vieira, EJ Barreiro, Process for obtaining calcium atorvastatin using novel intermediates, PI<br />

018110015039 (INPI, in 04/25/<strong>2011</strong>), PCT in december, <strong>2011</strong>.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!